Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing admin@sinochem-nanjing.com 3389378665@qq.com
Follow us:

7-Bromoquinazolin-(2,4)Dione

    • Product Name 7-Bromoquinazolin-(2,4)Dione
    • Alias NSC 673437
    • Einecs 242-544-9
    • Mininmum Order 1 g
    • Factory Site Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing
    • Price Inquiry admin@sinochem-nanjing.com
    • Manufacturer Sinochem Nanjing Corporation
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    132560

    Chemical Name 7-Bromoquinazolin-2,4-dione
    Molecular Formula C8H5BrN2O2
    Molecular Weight 241.05 g/mol
    Cas Number 5355-16-8
    Appearance White to off-white powder
    Melting Point 310-314 °C
    Solubility Slightly soluble in water, soluble in DMSO
    Boiling Point Decomposes before boiling
    Purity Typically ≥98%
    Storage Conditions Store at room temperature, protected from light and moisture

    As an accredited 7-Bromoquinazolin-(2,4)Dione factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing
    Shipping
    Storage
    Application of 7-Bromoquinazolin-(2,4)Dione

    Applications of 7-Bromoquinazolin-(2,4)Dione in Industrial Manufacturing

    As a direct manufacturer of 7-Bromoquinazolin-(2,4)Dione, we supply this pharmaceutical intermediate for regulated downstream uses supported by documented compliance, transparent specifications, and technical guidance relevant to high-precision formulation and process integration. Below we provide a practical overview of its principal industrial applications across the pharmaceutical, specialty chemical, and advanced materials sectors, highlighting technical details for each scenario.

    1. Small-Molecule Pharmaceutical Synthesis (Antineoplastic Agents)

    Leading oncology drug producers select this intermediate as a core scaffold in the preparation of quinazoline-based antineoplastic APIs. Its brominated position supports selective nucleophilic substitution, enabling construction of molecular analogs targeting kinase pathways. Formulators adjust input levels based on assay balance and desired yield, with in-process testing for residual toxicity. Batch records reflect integration at the earliest heterocycle assembly phase, supporting downstream purification and pharmaceutical-grade isolation.

    Industry compliance standards

    • ICH Q7 GMP Guideline - Active Pharmaceutical Ingredients
    • European Pharmacopoeia 11.0 Monographs (relevant to the API)
    • US FDA 21 CFR 211 (Finished Pharmaceuticals)
    • Chinese Pharmacopoeia (CP2020) for marketed APIs

    Typical usage ratio

    • 0.8–1.1 molar equivalents per synthesis batch, based on API route; ratio fine-tuned according to route optimization and API target yield

    Downstream process integration

    • Used during initial quinazoline core assembly in multi-step organic synthesis
    • Enters solution-phase or solid-phase nucleophilic displacement or palladium-catalyzed coupling
    • Precursor for further side-chain installation or aryl substitution at later stages

    Final product types

    • Antineoplastic active pharmaceutical ingredients (e.g., EGFR inhibitors, HER2 pathway inhibitors)
    • API intermediates for clinical candidates
    • Reference standards for QC and stability profiling

    2. Development of Analytical Reference Standards

    Analytical laboratories and pharmaceutical manufacturers rely on this compound as a certified reference standard during the validation of impurity profiling and content uniformity methods related to quinazoline-based drugs. Accurate quantification and traceability require raw material supplied with full CoA and batch traceability. Manufacturing integration occurs at the system suitability phase in HPLC or LC/MS, and reconstitution practices are defined by method validation protocols. Supply batches align with the sensitivity and selectivity requirements of regulatory filings.

    Industry compliance standards

    • USP General Chapter <823> Analytical Reference Standards
    • ISO/IEC 17025 Laboratory Accreditation
    • WHO Technical Report Series 1003 (Analytical Method Validation)
    • FDA cGMP for Laboratories (21 CFR 211 Subpart I)

    Typical usage ratio

    • 0.01–0.1% (w/w) in calibration standards or as spiking material; quantity determined by detection method LOQ and matrix complexity

    Downstream process integration

    • Dissolved in analytical-grade solvents for calibration curve preparation
    • Used as a system suitability, spike recovery, or limit test control in HPLC, LC/MS, and GC protocols
    • Enters validation runs for impurity quantitation and stability-indicating methods

    Final product types

    • Certified analytical standards for compendial methods
    • Impurity profile markers for pharmaceutical QC
    • Reference kits for regulatory method submissions

    3. Synthesis of Light-Sensitive Optical Materials

    Chemical manufacturers specializing in advanced optical films use this intermediate as a halogenated building block in synthesizing specialty dyes and UV-absorbing compounds. The precise location of the bromo group allows for regioselective introduction of electron-withdrawing substituents, tuning the photophysical profile of the finished product. Integration takes place at the coupling or cyclization stage, following strict process controls for residual halogen content and color consistency.

    Industry compliance standards

    • REACH Regulation (EC) No. 1907/2006
    • IEC 61249-2-21 (Halogen-Free Requirements for Electronic Substrates)
    • ISO 14001 Environmental Management (for specialty chemicals)
    • RoHS Directive (if components are intended for electronic displays)

    Typical usage ratio

    • 5–15% (w/w) depending on target chromophore intensity and film application

    Downstream process integration

    • Input at regioselective coupling or cyclocondensation for dye precursor synthesis
    • Carried into thin film casting or solution blending with matrix polymers
    • Post-synthesis purification by crystallization or column chromatography

    Final product types

    • UV-absorbing films for photolithography
    • Anti-counterfeiting security inks
    • High-performance pigments for specialty displays

    4. Preparation of Agrochemical Intermediates

    Agrochemical formulators incorporate this compound as a critical intermediate in the production of selective herbicide candidates and fungicidal agents based on quinazoline frameworks. The bromine substitution pattern enhances labile reactivity for further derivatization, supporting SAR-driven discovery for crop protection applications. Integration point occurs after core heterocycle formation and is followed by sequential alkylation or acylation steps, with process documentation following ISO and FAO specification documents.

    Industry compliance standards

    • FAO/WHO Pesticide Specifications Manual
    • ISO 9001:2015 Quality Management Systems (for agrochemicals)
    • OECD Principles of Good Laboratory Practice (GLP)
    • EU Regulation (EC) No 1107/2009 (Plant Protection Products)

    Typical usage ratio

    • 1.0–1.3 molar equivalents per target agrochemical batch; ratio adjusted for desired impurity profile and cost control

    Downstream process integration

    • Introduced in the mid-stage of active ingredient synthesis route
    • Subjected to nucleophilic aromatic substitution or cross-coupling
    • Followed by formulation into EW, SC, or WP products

    Final product types

    • Precursor for selective herbicides targeting broadleaf weeds
    • Intermediate for anti-fungal compounds adapted for cereal and fruit crops
    • Research compounds for mode-of-action studies

    5. Advanced Organic Electronic Materials R&D

    R&D units in organic electronics integrate this raw material at the synthesis phase for quinazoline-derived semiconductors and hole/electron transport layers, owing to the reactivity provided by the bromine substituent for Stille or Suzuki cross-coupling reactions. Specialized usage involves process documentation for purity and metal content, with ratio adjustment optimized according to device testing and solid-state performance. Batch traceability extends from lab-scale synthesis through upscaling for pilot fabrication of functional devices.

    Industry compliance standards

    • ISO/TS 80004-13:2017 (Nanotechnologies — Nanomaterials)
    • REACH Regulation (EC) No. 1907/2006
    • IPC-4101B (Electronic Substrate Quality Standards)
    • IATF 16949:2016 (for automotive electronics, if relevant)

    Typical usage ratio

    • 2–10% (w/w) as a reacting monomer depending on targeted polymer backbone and charge mobility testing data

    Downstream process integration

    • Reacted via Pd-catalyzed coupling to form conductive polymer or small molecule architectures
    • Material subjected to thin-film deposition, vacuum drying, or spin-coating depending on end device
    • Final purification by preparative chromatography for purity and electrical consistency

    Final product types

    • Organic semiconductor layers for OLED or OPV devices
    • Charge transport and injection layers in display technology
    • Performance reference materials for device characterization
    Free Quote

    Competitive 7-Bromoquinazolin-(2,4)Dione prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.

    We will respond to you as soon as possible.

    Tel: +8615371019725

    Email: admin@sinochem-nanjing.com

    Get Free Quote of Sinochem Nanjing Corporation

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    Introducing 7-Bromoquinazolin-(2,4)Dione: A New Chapter in Advanced Chemical Reagents

    Some products quietly raise the bar for an entire field. 7-Bromoquinazolin-(2,4)Dione lands squarely in that group. In labs where innovation feels both urgent and routine, people keep an eye out for compounds that keep pace with fresh ideas. This one does. Its molecular structure isn’t just a mouthful for chemists—it’s a workhorse in organic synthesis, setting itself apart from more common intermediates. Typically offered at a purity exceeding 98%, it delivers clean, reproducible reactions. Water content stays low, and the distinctive bromine atom in its makeup changes the game for selectivity and downstream applications.

    Model and Specifications: Chemistry That’s Built to Work

    You won’t find 7-Bromoquinazolin-(2,4)Dione on every shelf. Its formula, C8H4BrN2O2, gives a clue to its complexity and value. In the flask, it takes the form of a pale, almost chalk-white solid. Melt point hovers in the 300 degree Celsius range—useful when working at high-temperature benchmarks. Its solubility leans toward polar aprotic solvents, like dimethyl sulfoxide and dimethylformamide, which suits it for a raft of organic transformations. I’ve seen the ease with which this compound integrates into multi-step syntheses, its purity making small mistakes less likely. In research projects involving rare alkaloids, the fine physical quality translates into consistency, which is no small thing for scientists on a deadline.

    On the question of storage and handling, 7-Bromoquinazolin-(2,4)Dione responds well to the usual routine for light- and moisture-sensitive reagents. A sealed container, kept dry and shielded from pronounced temperature swings, keeps it stable for long stretches. The mild odor and minimal dust keep the bench pleasant—a sweet spot for chemists sensitive to more aggressive halogenated reagents.

    How Researchers Put 7-Bromoquinazolin-(2,4)Dione to Use

    Historical research shows quinazoline scaffolds pop up all over pharmaceutical science. That’s one reason synthetic chemists keep reaching for advanced derivatives, like 7-Bromoquinazolin-(2,4)Dione. Its core opens a path to new heterocycles, helping chemists craft building blocks for anti-cancer, anti-inflammatory, and anti-microbial compounds. The bromine substituent unlocks arylation, Suzuki couplings, and other palladium-catalyzed reactions that just don’t happen with simpler quinazoline diones.

    Early-career chemists I’ve worked with often get their first taste of bread-and-butter cross-coupling chemistry with brominated heterocycles, because the results arrive fast and clean. I’ve seen ideas move from concept to fragrant crystalline products thanks partly to reagents like this. The repeatability matters: researchers less seasoned with finicky intermediates find the straightforward reactivity makes training smoother. In exploratory projects, teams can test variations on a theme, tweaking functional groups around the Dione scaffold and learning quickly what works. That speeds up the pipeline in discovery programs.

    Beyond pharma, 7-Bromoquinazolin-(2,4)Dione sees attention in materials research. Its rigid aromatic system with halogen substituent makes it compelling for designing molecular sensors and thin-film electronics. Colleagues tell me about its role in testing new photoactive compounds, because it provides a stable core with a reactive “handle” for further transformation. Every lab loves a scaffold that works as a kind of molecular Swiss army knife.

    Standing Out from the Competition

    Brominated quinazoline diones land in a field crowded with analogues, each with small tweaks. Some options omit the bromine or swap it for other halogens. Those changes matter. In many syntheses, bromine's unique reactivity delivers both functional versatility and milder reaction conditions. I’ve seen teams using chlorinated versions run into roadblocks with palladium-catalyzed couplings. The coupling partners just don’t take as smoothly, and temperatures need nudging higher. That’s not only a drag on yield; it can prompt side reactions that muddy the product mix.

    In crowded fields like medicinal chemistry, being able to quickly and reliably install new groups onto a Dione core opens the door to drug candidates that stand out from the “me-too” molecules. 7-Bromoquinazolin-(2,4)Dione’s popularity doesn’t come from hype. Its performance in real projects—measured by higher yields, efficient purifications, and robust reproducibility—wins fans one bench at a time.

    Another plus: many standard heterocyclic intermediates can’t keep up with this product’s shelf life or handling ease. Researchers, especially in smaller or resource-limited labs, appreciate not having to order unstable reagents in tiny batches. Waste drops, and downtime from re-purifying batches disappears. That all adds up to more productive science, more of the time, with less stress among team members.

    Experienced Hands, Reliable Outcomes

    Reproducibility sits at the core of trustworthy science. Every time a reaction is run, a tiny bit of anxiety hangs over the process, especially with delicate or rare reagents. 7-Bromoquinazolin-(2,4)Dione takes some of the worry off the table. I’ve watched junior chemists find confidence in their technique because this reagent does what’s promised. That’s a breath of fresh air in a field where mystery byproducts or sluggish conversions can derail whole weeks of planning.

    The high purity, defined melting range, and resistance to common sources of degradation mean that small mistakes in handling don’t spiral into bigger issues. Researchers can focus on trying new catalyst systems or scaling up exploratory syntheses, trusting that the reagent delivers consistent results. In one collaboration, the freedom to run reactions at decent scales—without daily re-purification—let us move through a library of target compounds in record time. I remember the feeling of momentum on that project, where every day in the lab moved things forward, not sideways.

    Education benefits too. For those just getting started, tactile exposure to stable, bench-friendly reagents builds foundational skills. Troubleshooting becomes an exercise in method, not a guessing game about compound freshness or stability. That kind of environment breeds better chemists and stronger science.

    Trust Through Experience: Transparency, Safety, and Results

    Transparency in composition builds trust. A lot of older quinazoline derivatives entered the market with unclear documentation or inconsistent quality control. Times are changing. Detailed spectral data—proton and carbon NMR, high-res mass spectrometry, and IR—conform to modern standards for publishing and regulatory submission. Whether developing an IND package or chasing a publishable synthetic sequence, reliable characterization speeds up the process.

    Health and safety rule every bench, and brominated derivatives have a reputation that precedes them. I’ve worked with a lot of halogenated intermediates, and many release harsh vapors or provoke skin irritation after a few hours in the hood. 7-Bromoquinazolin-(2,4)Dione’s relative mildness surprised me. While good lab hygiene stays non-negotiable, concerns around persistent odor, difficult cleanup, or runoff toxicity haven’t come up in my experience. Teams can use it more broadly, with less restrictive handling protocols, opening doors to training and collaborative work.

    Green chemistry features matter in today’s research world, too. Fewer purification runs and more predictable conversions mean less waste. Students in my lab saw this firsthand: fewer messy column runs meant hours saved and waste containers kept lighter. That’s real-world progress toward sustainable lab practices. With the pace of environmental regulation picking up worldwide, this kind of product slots into projects looking to limit solvent and reagent footprints.

    Practical Challenges and Room for Improvement

    No chemical is perfect, and 7-Bromoquinazolin-(2,4)Dione is no exception. Advanced users sometimes run into batch-to-batch variation in bulk lots, mostly a headache in the rare event of poorly controlled supply chains. Direct, long-term relationships with reputable suppliers smooth over most of those bumps, helping labs avoid the unfortunate surprise of off-specification product. A broader challenge sits in scale. Since it’s mainly used in exploratory and development phases, widespread adoption in manufacturing has yet to arrive. That becomes a chicken-and-egg story: without larger orders, price stays above the reach of cash-strapped academic groups.

    Some researchers move away from brominated options due to environmental concerns about halogenated waste, even if the risks are modest in controlled lab settings. Solutions there rest on developing greener downstream protocols—routes where recovery and recycling of spent catalysts and solvents reach higher percentages. In my group, we’ve tackled this by introducing work-up and purification steps that use less hazardous materials. Progress comes in small increments, often by building on the reliability of clean initial reactions. Less time spent debugging unintended side products leaves headspace for process improvements, both chemical and environmental.

    The path to better access runs through smarter partnerships. Distributors attuned to smaller-batch, specialty product needs improve availability. Some have begun to offer custom packaging or joint purchasing programs, cutting down on waste and opening the door to academic pricing. These tweaks help stretch slim budgets further, getting innovative reagents into the hands of more students and early-career scientists.

    The Road Ahead: Why 7-Bromoquinazolin-(2,4)Dione Matters

    Discovery rewards those who break out of chemical ruts. 7-Bromoquinazolin-(2,4)Dione supplies a nimble, reliable scaffold for pushing into new ground—whether that means a fresh route to a clinical candidate or the backbone of a novel material for sensors and electronics. The right reagent shapes careers, not just reactions. I think back to my first project using a similar advanced intermediate: walking into the lab with the product in hand, the anticipation of new chemistry at my fingertips. There’s a spark that comes from working with a product engineered for precision and reliability.

    Growing up in research, I watched colleagues wrestle with inconsistent reactants. Some would stock up on “tried and true” compounds, missing out on newer scaffolds out of habit or risk aversion. The tide has turned with advanced heterocyclic reagents like this one, which reward a willingness to try the unfamiliar. Their adoption shapes entire research trajectories, accelerating the journey from the bottom of the fume hood to the top of the journal table of contents.

    Worldwide, the hunger for streamlined synthesis continues to climb. Papers published in high-impact journals increasingly cite the use of advanced quinazoline derivatives as core pieces of innovative synthetic sequences. That’s no coincidence. Scientists want adaptable, reproducible platforms—reagents that can play supporting roles in both mainstream and exploratory efforts. In classrooms, the next wave of chemists now learns with safer, simpler intermediates, building confidence and skill from their first reactions. That’s a chain reaction that ripples outward, shaping a culture of curiosity, care, and capability.

    Innovation Made Practical, Science Made Productive

    For many teams, science doesn’t start with a fully mapped plan. It starts with a question, a hunch, and the right tool for the moment. Advanced reagents empower teams to move past planning and into doing. 7-Bromoquinazolin-(2,4)Dione delivers that nudge—a bridge between old chemistry and the next achievement. Every paper, patent, and presentation owes something to reliable reactions. In my years at the bench, a dependable reagent makes the difference between a lost year and a book-worthy breakthrough.

    The virtues of 7-Bromoquinazolin-(2,4)Dione—clarity, reliability, adaptability—align with the demands of modern science. Researchers want results they can trust, scale, and repeat, and every thoughtful lab manager prizes products that remove uncertainty. This compound does more than catalyze reactions; it underpins the confidence to reach further, test hypotheses, and share findings openly. I’ve seen students set their sights higher when hands-on work with real-world reagents goes smoothly. In a world of growing challenges, that optimism isn’t just helpful; it’s necessary.

    In summary, 7-Bromoquinazolin-(2,4)Dione occupies a sweet spot in the modern chemistry toolkit. Strong characterization, reliable handling, broad synthetic access, and the ability to solve practical bottlenecks all work together in its favor. Cutting-edge research and effective training grow easier, safer, and smarter with access to such robust building blocks. My own journey through chemical research keeps reinforcing one lesson: the strongest science gets built on the steadiest foundations. For many chemists, 7-Bromoquinazolin-(2,4)Dione offers just that.